Joel Greenblatt's IBB Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 22,605 shares of iShares Biotechnology ETF (IBB) worth $3.82 M, representing 0.01% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in IBB, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's iShares Biotechnology ETF (IBB) Holding Value Over Time
Track share changes against reported price movement
Quarterly iShares Biotechnology ETF (IBB) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +22,605 | New Buy | 22,605 | $168.85 |
Joel Greenblatt's iShares Biotechnology ETF Investment FAQs
Joel Greenblatt first purchased iShares Biotechnology ETF (IBB) in Q1 2026, acquiring 22,605 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held iShares Biotechnology ETF (IBB) for 1 quarters since Q1 2026.
Joel Greenblatt's largest addition to iShares Biotechnology ETF (IBB) was in Q1 2026, adding 22,605 shares worth $3.82 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 22,605 shares of iShares Biotechnology ETF (IBB), valued at approximately $3.82 M.
As of the Q1 2026 filing, iShares Biotechnology ETF (IBB) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in iShares Biotechnology ETF (IBB) was 22,605 shares, as reported at the end of Q1 2026.